AstraZeneca

Trump Targets Corporate Deals Across 30+ Industries Before Midterm Elections

2025-10-04 00:00:00 +0000 UTC | Importance: 8/10

Trump administration systematically cut deals across more than 30 industries, trading tariff relief and federal financing for corporate concessions in a pattern resembling state-driven capitalism. Companies including Pfizer, Eli Lilly, and AstraZeneca faced pressure on production location and drug …

Trump Administration Pfizer Eli Lilly AstraZeneca Pharmaceutical Industry systematic-corruption state-corporate-fusion crony-capitalism institutional-capture

FDA Statistician Joan Buenconsejo Joins AstraZeneca After Overseeing Company Drug Reviews

2014-06-01 00:00:00 +0000 UTC | Importance: 7/10

Joan Buenconsejo, who led FDA analysis of medical statistics for drug reviews including AstraZeneca products in 2012-2013, joined AstraZeneca as a director and biometrics team leader in June 2014. This transition exemplifies the systemic ‘revolving door’ problem in pharmaceutical …

Joan Buenconsejo FDA AstraZeneca Center for Drug Evaluation and Research regulatory-capture pharmaceutical-industry fda revolving-door conflict-of-interest